Paper · 4123363

Delayed hypersensitivity: is the same population of thymus-derived cells responsible for cellular immunity reactions and the carrier effect?

Kettman J. Immunol Commun, 1972. Cited by 54 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Delayed hypersensitivity: is the same population of thymus-derived cells responsible for cellular immunity reactions and the carrier effect? Papers, record 4123363. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4123363

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Delayed hypersensitivity: is the same population of thymus-derived cells responsible for cellular immunity reactions and the carrier effect?; PubMed
Journal: Immunol Commun; PubMed
Year: 1972; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/4123363/; PubMed
DOI: https://doi.org/10.3109/08820137209022942; PubMed
The journal: https://conductscience.org/library/journal-index/0353016; PubMed
Citations, by iCite: 54; iCite
Relative citation ratio, by iCite: 1.15; iCite
Revised in PubMed: 2019-10-30; PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Kettman J	J

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Carrier Proteins	Major topic
Hypersensitivity, Delayed	Major topic
Immunity, Cellular	Major topic
T-Lymphocytes	Major topic
Animals
Antigen-Antibody Complex
Cross Reactions
Epitopes
Erythrocytes
Female
Immune Sera
Kinetics
Male
Mice
Spleen

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMID	Title	Journal	Year	In Papers	Source
32,041,943	STAT3 activates MSK1-mediated histone H3 phosphorylation to promote NFAT signaling in gastric carcinogenesis.	Oncogenesis	2020	https://conductscience.org/library/papers/32041943	PubMed
6,978,602	A delayed-type hypersensitivity reaction initiated by a single T lymphocyte.	Agents Actions	1981	https://conductscience.org/library/papers/6978602	PubMed
6,822,405	Influence of dietary protein restriction on the delayed-type hypersensitivity response to sheep red blood cells in mice.	Immunology	1983	https://conductscience.org/library/papers/6822405	PubMed
4,598,017	Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.	J Exp Med	1974	https://conductscience.org/library/papers/4598017	PubMed
4,591,171	Feedback inhibition of specifically sensitized lymphocytes.	J Exp Med	1974	https://conductscience.org/library/papers/4591171	PubMed
4,544,249	Lack of a correlation between cell-mediated immunity to the carrier and the carrier-hapten helper effect.	J Exp Med	1974	https://conductscience.org/library/papers/4544249	PubMed
4,120,287	Regulation of the immune response. II. Qualitative and quantitative differences between thymus- and bone marrow-derived lymphocytes in the recognition of antigen.	J Exp Med	1973	https://conductscience.org/library/papers/4120287	PubMed
3,712,557	Pathogenicity of fibroblast- and lymphocyte-specific variants of minute virus of mice.	J Virol	1986	https://conductscience.org/library/papers/3712557	PubMed
1,165,473	Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions.	J Exp Med	1975	https://conductscience.org/library/papers/1165473	PubMed
1,117,258	Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.	J Exp Med	1975	https://conductscience.org/library/papers/1117258	PubMed

1 to 10 of 15

See all 15 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4123363

GET https://conductscience.org/api/papers/v1/4123363/authors

API reference For AI assistants